{"id":"NCT04186845","sponsor":"Blue Earth Diagnostics","briefTitle":"Imaging Study to Investigate Safety and Diagnostic Performance of 18F rhPSMA 7.3 PET Ligand in Suspected Prostate Cancer Recurrence","officialTitle":"A Prospective, Phase 3, Multi Center, Single-arm, Imaging Study Investigating the Safety and Diagnostic Performance of rhPSMA 7.3 (18F) PET Ligand in Men With Suspected Prostate Cancer Recurrence Based on Elevated PSA Following Prior Therapy (SPOTLIGHT)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2020-05-04","primaryCompletion":"2021-04-28","completion":"2021-04-28","firstPosted":"2019-12-05","resultsPosted":"2025-02-26","lastUpdate":"2025-02-26"},"enrollment":391,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"DIAGNOSTIC"},"conditions":["Prostate Cancer"],"interventions":[{"type":"DRUG","name":"rhPSMA-7.3 (18F) Injection","otherNames":["flotufolastat F18"]},{"type":"DIAGNOSTIC_TEST","name":"Positron emission tomography scan","otherNames":["PET scan"]}],"arms":[{"label":"Patients","type":"EXPERIMENTAL"}],"summary":"A prospective, Phase 3, multi center, single-arm, imaging study investigating the safety and diagnostic performance of rhPSMA 7.3 (18F) Positron Emission Tomography (PET) ligand in men with suspected prostate cancer recurrence based on elevated Prostate-specific antigen (PSA) following prior therapy.","primaryOutcome":{"measure":"Patient-level CDR and Region-level PPV of rhPSMA7.3 (18F) PET for BCR of Prostate Cancer Using Histopathology or Imaging as a SoT","timeFrame":"Conventional images within 90 days of rhPSMA7.3 (18F) PET, followed by biopsy within 60 days post-PET scan or confirmatory imaging within 90 days post-PET scan","effectByArm":[{"arm":"Efficacy Analysis Population (EAP)","deltaMin":54.1,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"MALE","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":28,"countries":["United States","Finland","Netherlands"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":391},"commonTop":["Hypertension","Diarrhea","Injection site reaction","Headache","Flushing"]}}